SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-008242
Filing Date
2022-05-09
Accepted
2022-05-09 07:55:10
Documents
61
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vrca-20220331.htm   iXBRL 10-Q 1844612
2 EX-31.1 vrca-ex31_1.htm EX-31.1 17053
3 EX-31.2 vrca-ex31_2.htm EX-31.2 17353
4 EX-32.1 vrca-ex32_1.htm EX-32.1 15683
  Complete submission text file 0000950170-22-008242.txt   7187793

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrca-20220331_lab.xml EX-101.LAB 411824
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrca-20220331.xsd EX-101.SCH 41979
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrca-20220331_cal.xml EX-101.CAL 53483
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrca-20220331_pre.xml EX-101.PRE 285448
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrca-20220331_def.xml EX-101.DEF 166857
55 EXTRACTED XBRL INSTANCE DOCUMENT vrca-20220331_htm.xml XML 1374659
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38529 | Film No.: 22903278
SIC: 2834 Pharmaceutical Preparations